Sy Eric, Zacharias Sherma, Lee James S
Department of Critical Care, Saskatchewan Health Authority, Regina, CAN.
Cureus. 2022 Oct 30;14(10):e30877. doi: 10.7759/cureus.30877. eCollection 2022 Oct.
Neck swelling during venovenous extracorporeal membrane oxygenation (VV-ECMO) usually heralds the development of potentially serious complications, including superior vena cava (SVC) syndrome, hematoma, and/or angioedema. In this case report, we describe a 43-year-old male patient who had received VV-ECMO support for the coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome. During his hospitalization, he developed acute onset of neck swelling after two weeks of VV-ECMO and two days after a tracheostomy. Clinical examination and investigations were performed to exclude ECMO-related SVC syndrome and tracheostomy-related complications. Consequently, it was discovered the patient had developed COVID-19-related subacute thyroiditis with enlargement of both thyroid glands. Conservative management, including the use of continued glucocorticoids, raising the head of the bed, and observing for complications of thyroiditis, was undertaken. Eventually, this patient's neck swelling resolved on its own, and he was eventually decannulated from ECMO several weeks later. Our case report highlights the differential diagnosis of neck swelling during VV-ECMO and considers the evaluation of different etiologies.
静脉-静脉体外膜肺氧合(VV-ECMO)期间出现颈部肿胀通常预示着可能发生严重并发症,包括上腔静脉(SVC)综合征、血肿和/或血管性水肿。在本病例报告中,我们描述了一名43岁男性患者,他因2019冠状病毒病(COVID-19)急性呼吸窘迫综合征接受了VV-ECMO支持。在住院期间,他在接受VV-ECMO两周后且气管切开术后两天出现了急性颈部肿胀。进行了临床检查和调查以排除与ECMO相关的SVC综合征和与气管切开术相关的并发症。结果发现该患者患上了与COVID-19相关的亚急性甲状腺炎,双侧甲状腺肿大。采取了保守治疗,包括持续使用糖皮质激素、抬高床头以及观察甲状腺炎的并发症。最终,该患者的颈部肿胀自行消退,几周后他最终成功撤离了ECMO。我们的病例报告强调了VV-ECMO期间颈部肿胀的鉴别诊断,并考虑了对不同病因的评估。